Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2010 1
2011 2
2012 1
2013 3
2017 6
2018 4
2019 3
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Vogelzang NJ, Pal SK, Ghate SR, Li N, Swallow E, Peeples M, Zichlin ML, Meiselbach MK, Perez JR, Agarwal N. Vogelzang NJ, et al. Among authors: ghate sr. J Manag Care Spec Pharm. 2018 Jun;24(6):525-533. doi: 10.18553/jmcp.2018.24.6.525. J Manag Care Spec Pharm. 2018. PMID: 29799328
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.
Reynolds SL, Ghate SR, Sheer R, Gandhi PK, Moretz C, Wang C, Sander S, Costantino ME, Annavarapu S, Andrews G. Reynolds SL, et al. Among authors: ghate sr. Health Qual Life Outcomes. 2017 Jun 21;15(1):128. doi: 10.1186/s12955-017-0705-x. Health Qual Life Outcomes. 2017. PMID: 28637460 Free PMC article.
28 results